sign in
join free
verified
Copper
Kodia Biotechnology Inc
verified
Kodia Biotechnology Inc
Henan,China
Kodia Biotechnology Inc
Henan,China
verified
Copper Member
Kodia Biotechnology Inc
favorite supplier
verified
Copper Member
Kodia Biotechnology Inc
Henan,China
Scan QR code
Access to mobile station
Human Papillomavirus (HPV) E6/E7 mRNA Detection Kit (Branched DNA signal amplification method)
FOB Price : Get Latest Price
Min.Order : 92Piece(s)
Payment Terms : L/C,T/T,D/P
contact now
Kodia Biotechnology Inc
Kodia Biotechnology Inc. (Kodia) is in Building 23 of Zhengzhou High-tech International Enterprise Port. It is committed to the research and development, production and sales of molecular/molecular pathology diagnostic products, focusing on technology research and development, reagent production, inspection and testing services, scientific research collaboration, etc.
Kodia has its own patented technology, QuantiMAT platform, the HPV E6/E7 mRNA detection kit, is the first domestic cervical cancer screening product used to assess the risk of cervical cancer. It is the "First in the Country" selection into the "Innovative Medical Device Product Catalog" of the Ministry of Science and Technology. This platform has served hundreds of hospitals and testing institutions and has become an effective tool for physicians to assess the risk of cervical cancer.
The research and development division of Kodia is led by around ten PhDs in medicine, oncology, molecular biology, chemistry, mass spectrometry and other fields. In addition to the self-developed QuantiMAT platform, Kodia has extensive experiences in scientific research technologies such as IHC, FISH, RT-PCR, and multiplex PCR. On these platforms, scientific research and development and other work are carried out, mainly involving the screening, production of relevant molecular nucleic acid targets in various solid tumors, early tumor screening, infection, maternal and child health, etc.
+
More
Kodia has its own patented technology, QuantiMAT platform, the HPV E6/E7 mRNA detection kit, is the first domestic cervical cancer screening product used to assess the risk of cervical cancer. It is the "First in the Country" selection into the "Innovative Medical Device Product Catalog" of the Ministry of Science and Technology. This platform has served hundreds of hospitals and testing institutions and has become an effective tool for physicians to assess the risk of cervical cancer.
The research and development division of Kodia is led by around ten PhDs in medicine, oncology, molecular biology, chemistry, mass spectrometry and other fields. In addition to the self-developed QuantiMAT platform, Kodia has extensive experiences in scientific research technologies such as IHC, FISH, RT-PCR, and multiplex PCR. On these platforms, scientific research and development and other work are carried out, mainly involving the screening, production of relevant molecular nucleic acid targets in various solid tumors, early tumor screening, infection, maternal and child health, etc.
leave a message
-
phone :
view details
-
address :
Building 23, High-tech International Enterprise Port, No. 352 Lianhua Street, High-tech Zone, Zhengzhou City, Henan Province
-
postcode :
450000
-
website :
https://www.kodiabio.com/